p53 expression in K562 cells is associated with caspase-mediated cleavage of c-ABL and BCR-ABL protein kinases-Reference-Cited by-同舟云学术

p53 expression in K562 cells is associated with caspase-mediated cleavage of c-ABL and BCR-ABL protein kinases

Published:2002-05-19 Issue:3 Volume:117 Page:588-597
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Di Bacco Alessandra M. A.,Cotter Thomas G.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2002.03468.x/fullpdf

Reference54 articles.

1. Suppression of human colorectal carcinoma cell growth by wild-type p53;Baker;Science,1990

2. Nuclear c-Abl is a COOH-terminal repeated domain (CTD)-tyrosine (CTD)-tyrosine kinase-specific for the mammalian RNA polymerase II: possible role in transcription elongation;Baskaran;Cell Growth Differentiation,1999

3. Lineage-specific requirement of c-abl function in normal hematopoiesis;Caracciolo;Science,1989

4. Suppression of acute lymphoblastic leukemia by the human wild-type p53 gene;Cheng;Cancer Research,1992

5. p53-mediated differentiation of the erythroleukemia cell line K562;Chylicki;Cell Growth Differentiation,2000

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CX‑5461 potentiates imatinib‑induced apoptosis in K562 cells by stimulating KIF1B expression;Experimental and Therapeutic Medicine;2024-01-18

2. siRNA-mediated downregulation of BATF3 diminished proliferation and induced apoptosis through downregulating c-Myc expression in chronic myelogenous leukemia cells;Molecular Biology Reports;2024-01-13

3. Isoalantolactone mediates the degradation of BCR-ABL protein in imatinib-resistant CML cells by down-regulating survivin;Cell Cycle;2023-05-18

4. An Integrative Informatics Approach to Explain the Mechanism of Action of N1-(Anthraquinon-2-yl) Amidrazones as BCR/ABL Inhibitors;Current Computer-Aided Drug Design;2021-12

5. Brefeldin A Induces Apoptosis, Inhibits BCR-ABL Activation, and Triggers BCR-ABL Degradation in Chronic Myeloid Leukemia K562 Cells;Anti-Cancer Agents in Medicinal Chemistry;2021-06-08